PCN19 A COST-CONSEQUENCE ANALYSIS OF DARBEPOETIN ALFA ADMINISTERED EVERY 3 WEEKS (Q3W DA) COMPARED TO WEEKLY EPOETIN ALFA (QW EA) OR EPOETIN BETA (QW EB) IN PATIENTS WITH CHEMOTHERAPY-INDUCED ANEMIA (CIA)-THE GERMAN CASE
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65177-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)65177-7/fulltext
Title :
PCN19 A COST-CONSEQUENCE ANALYSIS OF DARBEPOETIN ALFA ADMINISTERED EVERY 3 WEEKS (Q3W DA) COMPARED TO WEEKLY EPOETIN ALFA (QW EA) OR EPOETIN BETA (QW EB) IN PATIENTS WITH CHEMOTHERAPY-INDUCED ANEMIA (CIA)-THE GERMAN CASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65177-7&doi=10.1016/S1098-3015(10)65177-7
First page :
Section Title :
Open access? :
No
Section Order :
337